<!doctype html>
<html lang="en">
  <head>
    <link rel="canonical" href="https://neweramabs.com" />
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Innovative Antibody Solutions | 4x Faster Antibody Discovery with new/era/mabs</title>

    <!-- Meta SEO -->
    <meta name="title" content="Innovative Antibody Solutions | 4x Faster Antibody Discovery with new/era/mabs" />
    <meta
      name="description"
      content="Discover groundbreaking antibody solutions with new/era/mabs. Our scalable platform accelerates antibody discovery and manufacturing across murine, human, and camelid sources, delivering results four times faster than conventional methods. Partner with us for tailored, rapid, and infinite screening options, ensuring precise diagnostics and therapeutics for future pandemics and diverse research needs."
    />
    <meta name="robots" content="index, follow" />
    <meta name="language" content="English" />
    <meta name="author" content="new/era/mabs" />

    <!-- Social Media Share -->
    <meta property="og:title" content="Innovative Antibody Solutions | 4x Faster Antibody Discovery with new/era/mabs" />
    <meta property="og:site_name" content="new/era/mabs" />
    <meta property="og:url" content="https://neweramabs.com" />
    <meta
      property="og:description"
      content="Discover groundbreaking antibody solutions with new/era/mabs. Our scalable platform accelerates antibody discovery and manufacturing across murine, human, and camelid sources, delivering results four times faster than conventional methods. Partner with us for tailored, rapid, and infinite screening options, ensuring precise diagnostics and therapeutics for future pandemics and diverse research needs."
    />
    <meta property="og:type" content="website" />
    <!-- <meta property="og:image" content="https://neweramabs.com/assets/nem-selma.jpg" /> -->

    <!-- Favicon -->
    <!-- `sizes="any"` is to fix Chrome bug -->
    <link rel="icon" href="/favicon.ico" sizes="any" />
    <link rel="icon" href="/icon.svg" type="image/svg+xml" />
    <link rel="apple-touch-icon" href="/apple-touch-icon.png" />
    <link rel="manifest" href="/manifest.webmanifest" />

    <link href="css/nem.css" rel="stylesheet" />
    <script async defer src="https://buttons.github.io/buttons.js"></script>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.2/css/all.min.css" />
  </head>
  <body>
    <header class="fixed z-50 w-full">
      <nav class="border-gray-200 bg-white py-2.5">
        <div class="mx-auto flex max-w-screen-xl flex-wrap items-center justify-between px-4">
          <a href="/" class="flex items-center">
            <img src="assets/nem-logo.svg" class="mr-3 h-6 sm:h-9" alt="new/era/mabs home" />
          </a>
          <div class="flex items-center lg:order-2">
            <a
              href="#"
              class="rounded-lg bg-nem-light px-4 py-2 text-sm font-medium text-nem-dark hover:bg-nem-300 focus:outline-none focus:ring-4 focus:ring-nem-300 sm:mr-2 lg:mr-0 lg:px-5 lg:py-2.5"
              >Contact Us</a
            >
            <button
              data-collapse-toggle="mobile-menu-2"
              type="button"
              class="ml-1 inline-flex items-center rounded-lg p-2 text-sm text-gray-500 hover:bg-gray-100 focus:outline-none focus:ring-2 focus:ring-gray-200 lg:hidden"
              aria-controls="mobile-menu-2"
              aria-expanded="false"
            >
              <span class="sr-only">Open main menu</span>
              <svg class="h-6 w-6" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                <path
                  fill-rule="evenodd"
                  d="M3 5a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zM3 10a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zM3 15a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1z"
                  clip-rule="evenodd"
                ></path>
              </svg>
              <svg class="hidden h-6 w-6" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                <path
                  fill-rule="evenodd"
                  d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z"
                  clip-rule="evenodd"
                ></path>
              </svg>
            </button>
          </div>
          <div class="hidden w-full items-center justify-between lg:order-1 lg:flex lg:w-auto" id="mobile-menu-2">
            <ul class="mt-4 flex flex-col font-medium lg:mt-0 lg:flex-row lg:space-x-8">
              <li>
                <a
                  href="science.html"
                  class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-nem-500 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  aria-current="page"
                  >Our Science</a
                >
              </li>
              <li>
                <a href="diseasex.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >Disease X</a
                >
              </li>
              <li>
                <a href="service.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >Service</a
                >
              </li>
              <li>
                <a href="products.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >Products</a
                >
              </li>
              <li>
                <a href="about.html" class="lg: lg: block border-b border-gray-100 py-2 pl-3 pr-4 text-gray-700 hover:bg-gray-50 lg:border-0 lg:p-0 lg:hover:bg-transparent lg:hover:text-nem-500"
                  >About Us</a
                >
              </li>
            </ul>
          </div>
        </div>
      </nav>
    </header>

    <!-- Start block -->
    <section class="bg-nem-100 pt-20 lg:pt-28">
      <div class="mx-auto grid max-w-screen-xl px-4 pb-8 lg:grid-cols-12 lg:gap-8 lg:py-16 xl:gap-0">
        <div class="relative z-20 mr-auto place-self-center lg:col-span-7">
          <h1 class="mb-4 max-w-2xl bg-gradient-to-r from-nem-dark to-nem-light bg-clip-text pb-3 text-4xl font-extrabold tracking-tight text-transparent md:text-5xl xl:text-6xl">
            Discover Antibodies with selma: A Game-Changer!
          </h1>
          <p class="mb-6 max-w-2xl font-light text-gray-500 md:text-lg lg:mb-8 lg:text-xl">Innovate Access to New Technologies and Personalized Healthcare Solutions.</p>
        </div>
        <div class="relative z-20 hidden lg:col-span-5 lg:mt-0 lg:flex">
          <div class="overflow-hidden rounded-3xl shadow-2xl shadow-nem-800">
            <!-- <img src="" alt="Hero Image" class="size-96 opacity-80" /> -->
          </div>
        </div>
      </div>
    </section>
    <!-- End block -->
    <!-- Start block -->
    <section class="bg-gray-50">
      <div class="mx-auto max-w-screen-xl space-y-12 px-4 py-8 lg:space-y-20 lg:px-6 lg:py-24">
        <!-- Row -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Revolutionize Antibody Selection - meet selma</h2>
            <p class="mb-8 font-light lg:text-xl">
              Universally applicable, selma streamlines high-throughput screening by capturing antibodies in their natural form, allowing for early characterization and direct production without
              recloning. Flexible and efficient, it enables selection from 1 million antibody-producing cells per screening.
            </p>
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Mammalian cell display system to capture secreted antibodies</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Flexible and indefinite screening options for isotypes, cross-reactivities, affinities, and antigenic variants</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">High-throughput sorting and single cell plating</span>
              </li>
            </ul>
          </div>
          <div class="flex h-full items-center justify-center">
            <img class="max-h-52 rounded-lg" src="assets/nem-selma-principle.png" alt="selma principle" />
          </div>
        </div>
        <!-- Row Text Right -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="flex h-full items-center justify-center p-4">
            <div class="flex space-x-4">
              <img class="max-h-60 w-full rounded-lg" src="assets/nem-camAB.png" alt="Camelid antibodies" />
            </div>
          </div>
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Benefits of Camelid antibodies</h2>
            <p class="mb-8 font-light lg:text-xl">
              Camelid nanobodies are only one-tenth the size of a conventional antibody (12-15 kDa versus 150 kDa), making them the smallest antigen-binding moiety found in nature. Based on their
              single antigen binding site, they can adopt a specific finger-like structure to recognize and bind hidden or buried target epitopes.
            </p>
            <!-- List -->
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Superior binding affinities</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Ease of humanization</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Low immunogenicity</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Deep tissue penetration</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Excellent solubility and high stability</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Easy and cheap manufacturing</span>
              </li>
            </ul>
            <p class="font-light lg:text-xl">These properties can be translated into novel forms of antibody-based diagnostic products and drug therapies.</p>
          </div>
        </div>

        <!-- Row Text Left -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Epitope-specific immunization with viral carriers</h2>
            <p class="mb-8 font-light lg:text-xl">
              We base our immunization strategy onto the most efficient danger signals to the mammalian immune system: viruses. By combining efficient surface-related epitopes with a viral particle
              system originated from the hamster polyomavirus, we are able to perform a hyper-immunization schedule, extraordinarily faster than conventional immunization strategies. We guarantee a
              surface-related presentation of the target epitope within the viral backbone.
            </p>
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">AI-based target and epitope profiling</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Surface-related epitope design</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Generation of unique viral-based immunoconjugates</span>
              </li>
            </ul>
            <p class="mb-8 font-light lg:text-xl">This flexibility provides the advantage of inducing a highly potent and antigen specific immune response to the native target.</p>
          </div>

          <div class="flex h-full items-center justify-center p-4">
            <div class="flex space-x-4">
              <img class="w-1/2 rounded-lg shadow-2xl" src="assets/nem-immunization1.png" alt="Immunization" />
              <img class="w-1/2 rounded-lg shadow-2xl" src="assets/nem-immunization2.png" alt="Immunization" />
            </div>
          </div>
        </div>

        <!-- Row Text Right -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="flex h-full items-center justify-center p-4">
            <div class="flex space-x-4">
              <img class="max-h-80 w-full rounded-lg" src="assets/nem-human.png" alt="Human antibodies" />
            </div>
          </div>
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Human antibody development</h2>
            <p class="mb-8 font-light lg:text-xl">
              Human antibodies are essential drugs for manifold diseases and well accepted therapeutic formats. With our in-house developed in vitro immunization process we are able to activate human
              naïve B lymphocytes antigen-specifically within 12 days and fuse them afterwards to obtain immortal hybridoma cell pools. Target-specific screening of candidates is performed with selma.
            </p>
            <!-- List -->
            <ul role="list" class="my-7 space-y-5 border-t border-gray-200 pt-8">
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">In vitro immunization with human B cells to create antigen-specific human cell pools</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Induction of different human IgG isotypes</span>
              </li>
              <li class="flex space-x-3">
                <!-- Icon -->
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                  <path
                    fill-rule="evenodd"
                    d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z"
                    clip-rule="evenodd"
                  ></path>
                </svg>
                <span class="text-base font-medium leading-tight text-gray-900">Selma selection and screening for high-performance binders</span>
              </li>
            </ul>
          </div>
        </div>

        <!-- Row Text Left -->
        <div class="items-center gap-8 lg:grid lg:grid-cols-2 xl:gap-16">
          <div class="text-gray-500 sm:text-lg">
            <h2 class="mb-4 text-3xl font-extrabold tracking-tight text-gray-900">Our Publications</h2>
            <ul class="space-y-4">
              <li class="flex items-start space-x-3">
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512">
                  <path d="M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V448c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128z" />
                </svg>
                <div class="flex-1">
                  <span class="text-base font-semibold leading-tight text-gray-900"> Meet selma: Novel antibody generation four times faster </span>
                  <div>
                    <span class="text-base font-medium leading-tight text-gray-500"
                      >This new/era/mabs article published in <strong>Research Features</strong> highlights the benefits working with our platform.</span
                    >
                  </div>

                  <div>
                    <a
                      href="https://researchfeatures.com/meet-selma-novel-antibody-generation-four-times-faster/"
                      target="_blank"
                      rel="noopener noreferrer"
                      class="mt-1 inline-flex items-center text-base font-bold text-nem-500 hover:text-nem-700"
                    >
                      Read the article
                      <svg class="ml-1 h-5 w-5" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                        <path
                          fill-rule="evenodd"
                          d="M12.293 5.293a1 1 0 011.414 0l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414-1.414L14.586 11H3a1 1 0 110-2h11.586l-2.293-2.293a1 1 0 010-1.414z"
                          clip-rule="evenodd"
                        ></path>
                      </svg>
                    </a>
                  </div>
                </div>
              </li>
              <li class="flex items-start space-x-3">
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512">
                  <path d="M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V448c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128z" />
                </svg>
                <div class="flex-1">
                  <span class="text-base font-semibold leading-tight text-gray-900">
                    A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line
                  </span>
                  <div>
                    <span class="text-base font-medium leading-tight text-gray-500">
                      This new/era/mabs article published in <strong>nature scientific reports</strong> describes our new antibody discovery platform selma.
                    </span>
                  </div>

                  <div>
                    <a
                      href="assets/neweramabs - A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line.pdf"
                      target="_blank"
                      rel="noopener noreferrer"
                      class="mt-1 inline-flex items-center text-base font-bold text-nem-500 hover:text-nem-700"
                    >
                      Read the article
                      <svg class="ml-1 h-5 w-5" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                        <path
                          fill-rule="evenodd"
                          d="M12.293 5.293a1 1 0 011.414 0l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414-1.414L14.586 11H3a1 1 0 110-2h11.586l-2.293-2.293a1 1 0 010-1.414z"
                          clip-rule="evenodd"
                        ></path>
                      </svg>
                    </a>
                  </div>
                </div>
              </li>
              <li class="flex items-start space-x-3">
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512">
                  <path d="M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V448c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128z" />
                </svg>
                <div class="flex-1">
                  <span class="text-base font-semibold leading-tight text-gray-900"> Selection of Antibodies Using selma Technology </span>
                  <div>
                    <span class="text-base font-medium leading-tight text-gray-500"> This new/era/mabs white paper describes highlights and use cases of selma.</span>
                  </div>

                  <div>
                    <a
                      href="assets/neweramabs - White Paper - Selection of Antibodies Using selma Technology.pdf"
                      target="_blank"
                      rel="noopener noreferrer"
                      class="mt-1 inline-flex items-center text-base font-bold text-nem-500 hover:text-nem-700"
                    >
                      Read the white paper
                      <svg class="ml-1 h-5 w-5" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                        <path
                          fill-rule="evenodd"
                          d="M12.293 5.293a1 1 0 011.414 0l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414-1.414L14.586 11H3a1 1 0 110-2h11.586l-2.293-2.293a1 1 0 010-1.414z"
                          clip-rule="evenodd"
                        ></path>
                      </svg>
                    </a>
                  </div>
                </div>
              </li>
              <li class="flex items-start space-x-3">
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512">
                  <path d="M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V448c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128z" />
                </svg>
                <div class="flex-1">
                  <span class="text-base font-semibold leading-tight text-gray-900"> How Nanobodies Open New Gates </span>
                  <div>
                    <span class="text-base font-medium leading-tight text-gray-500"> This new/era/mabs white paper describes workflows and use cases for camelid antibodies.</span>
                  </div>

                  <div>
                    <a
                      href="assets/neweramabs - White Paper - How Nanobodies Open New Gates.pdf"
                      target="_blank"
                      rel="noopener noreferrer"
                      class="mt-1 inline-flex items-center text-base font-bold text-nem-500 hover:text-nem-700"
                    >
                      Read the white paper
                      <svg class="ml-1 h-5 w-5" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                        <path
                          fill-rule="evenodd"
                          d="M12.293 5.293a1 1 0 011.414 0l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414-1.414L14.586 11H3a1 1 0 110-2h11.586l-2.293-2.293a1 1 0 010-1.414z"
                          clip-rule="evenodd"
                        ></path>
                      </svg>
                    </a>
                  </div>
                </div>
              </li>
              <li class="flex items-start space-x-3">
                <svg class="h-5 w-5 flex-shrink-0 text-nem-500" fill="currentColor" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512">
                  <path d="M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V448c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128z" />
                </svg>
                <div class="flex-1">
                  <span class="text-base font-semibold leading-tight text-gray-900"> selma Technology & Camelid Phage Display for the Discovery of Anti-SARS-CoV-2 Antibodies </span>
                  <div>
                    <span class="text-base font-medium leading-tight text-gray-500">
                      This new/era/mabs scientific poster shows selma for the selection of human antibodies and generation of SARS-CoV-2 camelid antibodies.</span
                    >
                  </div>

                  <div>
                    <a
                      href="assets/neweramabs - Poster - selma Technology & Camelid Phage Display for the Discovery of Anti-SARS-CoV-2 Antibodies.pdf"
                      target="_blank"
                      rel="noopener noreferrer"
                      class="mt-1 inline-flex items-center text-base font-bold text-nem-500 hover:text-nem-700"
                    >
                      Read the poster
                      <svg class="ml-1 h-5 w-5" fill="currentColor" viewBox="0 0 20 20" xmlns="http://www.w3.org/2000/svg">
                        <path
                          fill-rule="evenodd"
                          d="M12.293 5.293a1 1 0 011.414 0l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414-1.414L14.586 11H3a1 1 0 110-2h11.586l-2.293-2.293a1 1 0 010-1.414z"
                          clip-rule="evenodd"
                        ></path>
                      </svg>
                    </a>
                  </div>
                </div>
              </li>
            </ul>
          </div>

          <div class="flex h-full items-center justify-center p-4">
            <div class="flex space-x-4">
              <img class="max-h-80 w-full rounded-lg" src="assets/nem-nature-article.svg" alt="Publications" />
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- End block -->

    <footer class="bg-white">
      <div class="mx-auto max-w-screen-xl p-4 py-6 md:p-8 lg:p-10 lg:py-16">
        <div class="grid grid-cols-2 gap-8 md:grid-cols-3 lg:grid-cols-5">
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Our Science</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="#" class="hover:underline">About</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Careers</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Brand Center</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Blog</a>
              </li>
            </ul>
          </div>
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Help center</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="#" class="hover:underline">Discord Server</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Twitter</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Facebook</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Contact Us</a>
              </li>
            </ul>
          </div>
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Legal</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="#" class="hover:underline">Privacy Policy</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Licensing</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Terms</a>
              </li>
            </ul>
          </div>
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Our Science</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="#" class="hover:underline">About</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Careers</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Brand Center</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Blog</a>
              </li>
            </ul>
          </div>
          <div>
            <h3 class="mb-6 text-sm font-semibold uppercase text-gray-900">Download</h3>
            <ul class="text-gray-500">
              <li class="mb-4">
                <a href="#" class="hover:underline">iOS</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Android</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">Windows</a>
              </li>
              <li class="mb-4">
                <a href="#" class="hover:underline">MacOS</a>
              </li>
            </ul>
          </div>
        </div>
        <hr class="my-6 border-gray-200 sm:mx-auto lg:my-8" />
        <div class="text-center">
          <a href="#" class="mb-5 flex items-center justify-center text-2xl font-semibold text-gray-900">
            <img src="assets/nem-logo.svg" class="mr-3 h-6 sm:h-9" alt="new/era/mabs Logo" />
          </a>
          <span class="block text-center text-sm text-gray-500"
            >© new/era/mabs GmbH. All Rights Reserved. Built with
            <a href="https://flowbite.com" class="text-nem-500 hover:underline">Flowbite</a>
            and
            <a href="https://tailwindcss.com" class="text-nem-500 hover:underline">Tailwind CSS</a>.
          </span>
        </div>
      </div>
    </footer>
    <script type="module" src="main.js"></script>
  </body>
</html>
